Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Anika Therapeutics (ANIK) Asset Utilization Ratio (2016 - 2026)

Anika Therapeutics has reported Asset Utilization Ratio over the past 16 years, most recently at 0.63 for Q1 2026.

  • Quarterly Asset Utilization Ratio rose 5.69% to 0.63 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.63 through Mar 2026, up 5.69% year-over-year, with the annual reading at 0.57 for FY2025, 13.33% up from the prior year.
  • Asset Utilization Ratio was 0.63 for Q1 2026 at Anika Therapeutics, up from 0.59 in the prior quarter.
  • Over five years, Asset Utilization Ratio peaked at 0.63 in Q1 2026 and troughed at 0.33 in Q4 2022.
  • The 5-year median for Asset Utilization Ratio is 0.43 (2022), against an average of 0.46.
  • Year-over-year, Asset Utilization Ratio decreased 23.22% in 2023 and then surged 71.04% in 2025.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.33 in 2022, then grew by 23.5% to 0.4 in 2023, then skyrocketed by 36.91% to 0.55 in 2024, then increased by 7.58% to 0.59 in 2025, then grew by 5.85% to 0.63 in 2026.
  • Per Business Quant, the three most recent readings for ANIK's Asset Utilization Ratio are 0.63 (Q1 2026), 0.59 (Q4 2025), and 0.6 (Q3 2025).